Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Amgen: 4 Factors That Should Boost Stock
Seeking Alpha
Wednesday, May 4, 2011 - 11:25am
tags:
Amgen
Onyx Pharma 1Q loss grows as expenses rise
Yahoo/AP
Wednesday, May 4, 2011 - 11:24am
tags:
earnings, ONYX Pharmaceuticals
Lannett Awaits 3 Expected FDA Decisions
Seeking Alpha
Wednesday, May 4, 2011 - 11:24am
tags:
FDA, Lannett
Allergan reports lower profit
Marketwatch
Wednesday, May 4, 2011 - 11:14am
tags:
Allergan, earnings
Charles River Labs 1st-quarter profit surges on sale of early-stage business, but revenue dips
Yahoo/AP
Wednesday, May 4, 2011 - 9:58am
tags:
earnings, Charles River Laboratories
Exelixis' CEO Discusses Q1 2011 Results - Earnings Call Transcript
Seeking Alpha
Wednesday, May 4, 2011 - 9:57am
tags:
earnings, Exelixis
FTC Complains Pay-To-Delay Deals ‘Skyrocketed’
Pharmalot
Wednesday, May 4, 2011 - 9:55am
tags:
FTC, pay-for-delay, generics
Teva Strives to Meet Growth Targets With Cephalon Buy
Seeking Alpha
Wednesday, May 4, 2011 - 9:54am
tags:
Cephalon, M&A, Teva Pharmaceuticals
Cephalon 1Q profit surges on investment gain
Yahoo/AP
Wednesday, May 4, 2011 - 9:53am
tags:
earnings, Cephalon
Bayer’s Dekkers Looks for Stars to Align on Merger of Equals
Bloomberg
Wednesday, May 4, 2011 - 9:51am
tags:
Bayer, Pharma CEOs, M&A, Marijn Dekkers
The war over Lipitor
CNN/Fortune
Wednesday, May 4, 2011 - 9:49am
tags:
Lipitor, generics, Ranbaxy, Pfizer
Xoma botulism treatment starts early-stage government trial
Bizjournals.com
Tuesday, May 3, 2011 - 2:37pm
tags:
Xoma, botulinum toxin A
Cel-Sci: The Multikine Sweet 16
TheStreet.com
Tuesday, May 3, 2011 - 2:36pm
tags:
Cel-Sci, Multikine
Healthcare Companies on Remarkable Rise After a Decade-Long Decline
Seeking Alpha
Tuesday, May 3, 2011 - 2:34pm
tags:
Eli Lilly, Merck, Pfizer, Bristol-Myers Squibb
Valeant moves on to new M&A targets
Fierce Pharma
Tuesday, May 3, 2011 - 11:29am
tags:
Valeant Pharmaceuticals, M&A
Cell Therapeutics gets pixantrone news from FDA office
Bizjournals.com
Tuesday, May 3, 2011 - 11:28am
tags:
FDA, Cell Therapeutics, pixantrone
DNDN Cuts Loss on Provenge Sales
Yahoo/Zacks.com
Tuesday, May 3, 2011 - 11:26am
tags:
earnings, Dendreon
Alexza to raise $16.1M in direct offering
Bizjournals.com
Tuesday, May 3, 2011 - 11:26am
tags:
Alexza, stock offering
3 Biotech Stocks on the Edge of Success
Seeking Alpha
Tuesday, May 3, 2011 - 11:24am
tags:
Avanir, Sunesis, Ardea
Novo Nordisk Still One Of The Best Around
Investopedia
Tuesday, May 3, 2011 - 11:23am
tags:
Novo Nordisk

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.